30 july 2024
Global pharmaceutical companies must ensure compliant and ethical marketing and interaction with healthcare professionals and patients by adhering to the codes on promotional activities governing our industry worldwide. These are international rules and effective legislation on ethical pharmaceutical promotion applied at the national level.
Regulatory Affairs Departments must develop internal policies, processes, and training to ensure ethical principles are applied in marketing practices and that materials provide quality product information.
Good promotional practices require international rules to be adhered to by as many countries as possible, and effective legislation on ethical pharmaceutical promotion must be applied at the national level. The codes for promotional activities governing our industry are as follows :
The quality of healthcare provided to patients depends on the scientific information of medical products and the therapeutic environment made available to them. This information must, therefore, be scientifically accurate, transparent, and fair to promote good patient care.
This information is classified as “promotional” and “non-promotional.”
Promotion is any activity undertaken, organized, or supported by the company that aims to induce the prescription, recommendation, supply, administration, or consumption of products through any media.
All approved communications, materials, and messages created, disseminated by, or on behalf of the company that mention, characterize, or discuss a disease or product approved for marketing to induce its products’ prescription, recommendation, supply, administration, or consumption.
It includes all channels and media types, i.e., print, video, radio, and digital.
Non-promotion is the interaction and exchange of information between the company and external scientific communities to advance scientific and medical understanding. This includes information on the appropriate development and use of our medicines, understanding disease management of disease and improving patient care.
The core mission of promotional activities is to provide quality information on the product presented in compliance with the product’s marketing authorization and to promote the correct use of the product among healthcare professionals.
Promotional materials are based on scientifically proven results and undergo an internal review process to ensure they are objective and accurate before use.
Our PLG Regulatory Affairs teams can support you in reviewing your materials with regulatory experts in markets across the EU and globally who have expert knowledge of these local nuances and specifics. Contact us here.
Go to our Events to register
Go to our News to get insights